These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 12489321

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Osteoporosis in men.
    Seeman E.
    Baillieres Clin Rheumatol; 1997 Aug; 11(3):613-29. PubMed ID: 9367040
    [Abstract] [Full Text] [Related]

  • 4. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden.
    Mellström D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C.
    J Bone Miner Res; 2006 Apr; 21(4):529-35. PubMed ID: 16598372
    [Abstract] [Full Text] [Related]

  • 5. Preventing osteoporotic fractures in older people.
    McCloskey E.
    Practitioner; 2011 Jan; 255(1736):19-22, 2-3. PubMed ID: 21370710
    [Abstract] [Full Text] [Related]

  • 6. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR, Hamdy NA, Janssen YJ, Roelfsema F.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [Abstract] [Full Text] [Related]

  • 7. Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial.
    Sato Y, Iwamoto J, Kanoko T, Satoh K.
    Mov Disord; 2006 Jul; 21(7):924-9. PubMed ID: 16538619
    [Abstract] [Full Text] [Related]

  • 8. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L.
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [Abstract] [Full Text] [Related]

  • 9. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.
    Int J Clin Pharmacol Res; 2004 Sep; 24(1):1-10. PubMed ID: 15575171
    [Abstract] [Full Text] [Related]

  • 10. Inadequate dietary calcium intake in elderly patients with hip fractures.
    Lee YH, Lim YW, Ling PS, Tan YY, Cheong M, Lam KS.
    Singapore Med J; 2007 Dec; 48(12):1117-21. PubMed ID: 18043839
    [Abstract] [Full Text] [Related]

  • 11. Present and future of osteoporosis therapy.
    Seeman E, Tsalamandris C, Bass S, Pearce G.
    Bone; 1995 Aug; 17(2 Suppl):23S-29S. PubMed ID: 8579894
    [Abstract] [Full Text] [Related]

  • 12. Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.
    Muscoso E, Puglisi N, Mamazza C, Lo Giudice F, Testai M, Abbate S, Santangelo A, Panebianco P, Maugeri D.
    Eur Rev Med Pharmacol Sci; 2004 Aug; 8(2):97-102. PubMed ID: 15267123
    [Abstract] [Full Text] [Related]

  • 13. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ, Naganathan V, Barton I, Grauer A.
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [Abstract] [Full Text] [Related]

  • 14. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP.
    Arch Intern Med; 2003 Oct 13; 163(18):2237-46. PubMed ID: 14557222
    [Abstract] [Full Text] [Related]

  • 15. An investigation of the predictors of bone mineral density and response to therapy with alendronate in osteoporotic men.
    Drake WM, Kendler DL, Rosen CJ, Orwoll ES.
    J Clin Endocrinol Metab; 2003 Dec 13; 88(12):5759-65. PubMed ID: 14671165
    [Abstract] [Full Text] [Related]

  • 16. Osteoporosis Clinical Guideline. South African Medical Association--Osteoporosis Working Group.
    Hough S.
    S Afr Med J; 2000 Sep 13; 90(9 Pt 2):907-44. PubMed ID: 11081144
    [Abstract] [Full Text] [Related]

  • 17. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
    Shane E, Rodino MA, McMahon DJ, Addesso V, Staron RB, Seibel MJ, Mancini D, Michler RE, Lo SH.
    J Heart Lung Transplant; 1998 Nov 13; 17(11):1089-96. PubMed ID: 9855448
    [Abstract] [Full Text] [Related]

  • 18. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA.
    AIDS; 2007 Nov 30; 21(18):2473-82. PubMed ID: 18025884
    [Abstract] [Full Text] [Related]

  • 19. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A.
    Ann Acad Med Stetin; 2003 Nov 30; 49():111-30. PubMed ID: 15552843
    [Abstract] [Full Text] [Related]

  • 20. Preventing osteoporotic fractures with antiresorptive therapy: implications of microarchitectural changes.
    Boonen S, Haentjens P, Vandenput L, Vanderschueren D.
    J Intern Med; 2004 Jan 30; 255(1):1-12. PubMed ID: 14687233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.